BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30030324)

  • 1. Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4
    Kumar NA; van der Sluis RM; Mota T; Pascoe R; Evans VA; Lewin SR; Cameron PU
    J Immunol; 2018 Sep; 201(5):1468-1477. PubMed ID: 30030324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4(+) T-cells.
    Kumar NA; Cheong K; Powell DR; da Fonseca Pereira C; Anderson J; Evans VA; Lewin SR; Cameron PU
    Retrovirology; 2015 Sep; 12():76. PubMed ID: 26362311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
    Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.
    Anderson JL; Mota TM; Evans VA; Kumar N; Rezaei SD; Cheong K; Solomon A; Wightman F; Cameron PU; Lewin SR
    PLoS One; 2016; 11(7):e0158778. PubMed ID: 27383184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells.
    Evans VA; Kumar N; Filali A; Procopio FA; Yegorov O; Goulet JP; Saleh S; Haddad EK; da Fonseca Pereira C; Ellenberg PC; Sekaly RP; Cameron PU; Lewin SR
    PLoS Pathog; 2013; 9(12):e1003799. PubMed ID: 24339779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination Immune Checkpoint Blockade to Reverse HIV Latency.
    Van der Sluis RM; Kumar NA; Pascoe RD; Zerbato JM; Evans VA; Dantanarayana AI; Anderson JL; Sékaly RP; Fromentin R; Chomont N; Cameron PU; Lewin SR
    J Immunol; 2020 Mar; 204(5):1242-1254. PubMed ID: 31988180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway.
    van Montfort T; van der Sluis R; Darcis G; Beaty D; Groen K; Pasternak AO; Pollakis G; Vink M; Westerhout EM; Hamdi M; Bakker M; van der Putten B; Jurriaans S; Prins JH; Jeeninga R; Thomas AAM; Speijer D; Berkhout B
    EBioMedicine; 2019 Apr; 42():97-108. PubMed ID: 30824386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.
    Saleh S; Wightman F; Ramanayake S; Alexander M; Kumar N; Khoury G; Pereira C; Purcell D; Cameron PU; Lewin SR
    Retrovirology; 2011 Oct; 8():80. PubMed ID: 21992606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency.
    Evans VA; van der Sluis RM; Solomon A; Dantanarayana A; McNeil C; Garsia R; Palmer S; Fromentin R; Chomont N; Sékaly RP; Cameron PU; Lewin SR
    AIDS; 2018 Jul; 32(11):1491-1497. PubMed ID: 29746296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes.
    Redel L; Le Douce V; Cherrier T; Marban C; Janossy A; Aunis D; Van Lint C; Rohr O; Schwartz C
    J Leukoc Biol; 2010 Apr; 87(4):575-88. PubMed ID: 19801499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
    Van der Sluis RM; Zerbato JM; Rhodes JW; Pascoe RD; Solomon A; Kumar NA; Dantanarayana AI; Tennakoon S; Dufloo J; McMahon J; Chang JJ; Evans VA; Hertzog PJ; Jakobsen MR; Harman AN; Lewin SR; Cameron PU
    PLoS Pathog; 2020 Feb; 16(2):e1008151. PubMed ID: 32109259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.
    Kristoff J; Palma ML; Garcia-Bates TM; Shen C; Sluis-Cremer N; Gupta P; Rinaldo CR; Mailliard RB
    EBioMedicine; 2019 May; 43():295-306. PubMed ID: 30952614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4
    Agosto LM; Henderson AJ
    AIDS Res Hum Retroviruses; 2018 Sep; 34(9):780-789. PubMed ID: 29869531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.
    Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN
    Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.
    Zerbato JM; Serrao E; Lenzi G; Kim B; Ambrose Z; Watkins SC; Engelman AN; Sluis-Cremer N
    J Virol; 2016 Sep; 90(18):8059-73. PubMed ID: 27356901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CCR5
    Terahara K; Iwabuchi R; Hosokawa M; Nishikawa Y; Takeyama H; Takahashi Y; Tsunetsugu-Yokota Y
    BMC Res Notes; 2019 Apr; 12(1):242. PubMed ID: 31036079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell type-specific HIV-1 activation in effector T cells: implications for latent HIV-1 reservoir establishment.
    van der Sluis RM; van Capel TM; Speijer D; Sanders RW; Berkhout B; de Jong EC; Jeeninga RE; van Montfort T
    AIDS; 2015 Jun; 29(9):1003-14. PubMed ID: 25768834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
    Wonderlich ER; Subramanian K; Cox B; Wiegand A; Lackman-Smith C; Bale MJ; Stone M; Hoh R; Kearney MF; Maldarelli F; Deeks SG; Busch MP; Ptak RG; Kulpa DA
    PLoS Pathog; 2019 Oct; 15(10):e1008074. PubMed ID: 31609991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal.
    Moso MA; Anderson JL; Adikari S; Gray LR; Khoury G; Chang JJ; Jacobson JC; Ellett AM; Cheng WJ; Saleh S; Zaunders JJ; Purcell DFJ; Cameron PU; Churchill MJ; Lewin SR; Lu HK
    AIDS; 2019 Feb; 33(2):199-209. PubMed ID: 30562171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes.
    Cameron PU; Handley AJ; Baylis DC; Solomon AE; Bernard N; Purcell DF; Lewin SR
    J Virol; 2007 Mar; 81(5):2297-306. PubMed ID: 17166903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.